About us

Eva joined Pfizer in 1991 and has held roles of increasing responsibility in different geographic regions within public affairs, government affairs, brand public affairs, and commercial support. She is a member of Pfizer’s Global Policy Leadership team and provides support to Pfizer’s Executive Leadership team. More recently Eva was Head of Pfizer’s European Government Affairs operations/EU Office, and from December 2020 Vice-President Global Policy International Developed Markets Leads with 56 market-based policy and public affairs colleagues reporting into her organization. Eva is a lawyer by training, specialised in European law, IP and trade law. She obtained a Master’s Degree in Law from the University of Copenhagen and a Post-Graduate Degree in European Law from Université Libre de Bruxelles (ULB). She also holds qualifications in Leadership from INSEAD.
Eva Grut-Aandahl
Vice President, Global Policy and Public Affairs, International Developed Markets
Andrea Chiarello
Andrea joined Pfizer in 2015 and in December 2020 he became Director, Head of EU Government Affairs. In his current role, he coordinates Pfizer’s EU external engagement strategy and manages relationships with key trade associations such as EFPIA, AmCham EU and EuropaBio. His areas of focus include the Pharmaceutical Strategy for Europe, intellectual property (IP) incentives, antimicrobial resistance (AMR) and gene therapy. In addition, Andrea is the founder and current manager of the @PfizerEUPolicy Twitter account and the pfizereupolicy.eu website. Andrea holds a M.A. in EU Diplomacy from the College of Europe (Bruges campus) and a M.A. in EU policies from Padua University (Italy) and the Institut D’Etudes Politiques (IEP) of Strasbourg. An Italian national, he speaks English, French, Spanish and basic Serbo-Croatian. He is married and proud father of Ines since February 2021.
Andrea Chiarello
Director, Head of EU Government Affairs
Franjo joined Pfizer’s EU Government Affairs team in 2019. His areas of focus include oncology policy, digital health, research and innovation, and patient advocacy matters. He works closely with key trade associations such as EFPIA and EuropaBio, and manages relationships with external partners, such as Science|Business and EU umbrella patient advocacy groups. Previously Franjo worked for Merck KGaA in Brussels and Darmstadt, interned in the European Commission's DG SANTE and was a consultant in pharma regulatory affairs in Barcelona. Franjo obtained a Master's Degree in Pharmacy from the University of Zagreb. A Croatian national, he speaks English, Italian, Spanish, German and French.
Franjo Čaić
Senior Manager, EU Government Affairs
Charles Faid
Charles is a member of Pfizer’s Global Trade Policy team. He focuses on a range of areas including FTAs, transatlantic trade, and supply chains. He chairs the International Working Group of the European pharmaceutical trade association EFPIA. Previously Charles was a Director in Pfizer’s EU Government Affairs team, where he worked on areas including anti-counterfeiting, intellectual property and trade, as well as policy support to the commercial business. He holds an MA in German from the University of Edinburgh, and an MA in Politics, Security and Integration from the School of Slavonic and East European Studies (SSEES), University College London.
Charles Faid
Director, Global Trade Policy
Heike Galbraith
Heike has almost 20 years of experience in European Public Affairs, and first joined Pfizer in 2003. She is managing Pfizer’s engagement in the trade association Vaccines Europe, and is leading public affairs strategies in support of several franchises both in Vaccines and Rare Diseases. While working for Gilead between 2008 and 2010, Heike helped build their International Government Affairs team, and led pan-European and national programmes to improve early diagnosis and care in HIV/AIDS and hepatitis. Prior to joining Pfizer, Heike worked in the European Parliament and as consultant in two global communications firms. Heike holds a Master’s Degree in History, Politics and Public Law from the University of Heidelberg.
Heike Galbraith
Director, Global Vaccines & Rare Disease Public Affairs